ARCHIMED
Rohit Singh is a finance professional with extensive experience in investor relations and corporate finance. As a Senior Analyst for Investor Relations at ARCHIMED since March 2023, Rohit focuses on impacting healthcare through strategic financial communication. Previously, as a Junior Treasury & Investor Relations Coordinator at ADVA, Rohit managed daily cash operations, developed investor presentation materials, analyzed foreign exchange strategies, and supported sustainable supplier initiatives. Prior roles include a Venture Capital Analyst at Merck Group, where Rohit conducted due diligence and portfolio management, and a Credit Analyst for Corporate Bonds at UniCredit, focusing on financial modeling and operational analysis. Rohit holds an MSc in Finance from Grenoble Ecole de Management and is a CFA Level 2 candidate.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.